Bioactive Wound Management Market - Global Industry Analysis

Bioactive Wound Management Market By Product (Alginate Dressing, Antimicrobial Dressing, and Hydrocolloids Dressing), End-User (Hospitals, Clinics, Long-term Patient Care, Home Care Settings, and Other), and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

Published Date: 11-Jul-2022 Category: Healthcare Report Format : PDF Pages: 255 Report Code: ZMR-2988 Status : Published

With a compound annual growth rate (CAGR) of around 7.9 percent during the projected period, the global bioactive wound management market is predicted to increase in value from USD 1.8 billion in 2021 to USD 2.9 billion by 2028.

Description

Bioactive Wound Management Market Size And Forecast

With a compound annual growth rate (CAGR) of around 7.9 percent during the projected period, the global bioactive wound management market size is predicted to increase in value from USD 1.8 billion in 2021 to USD 2.9 billion by 2028. The drivers, restraints/challenges, and their effects on demand throughout the projected period are examined in the study for the bioactive wound management market. The research also investigates new potential in the bioactive wound management market.

Bioactive Wound Management Market: Overview

A variety of wound dressings are available on the bioactive wound care market. The wound dressings in this business are renowned for their microbial infection-fighting capabilities and biodegradable qualities. Additionally, these wound dressings include an antibiotic component that promotes healing and prevents infections. The traditional wound-healing products are being replaced with bioactive wound care items. When compared to bioactive wound care treatments, the older, more conventional wound healing therapies are less successful. The bioactive wound care solutions are both cost-effective and speed up wound healing.

Global Bioactive Wound Management Market

COVID-19 Impact:

Global medical care delivery has transformed as a result of the COVID-19 pandemic. Numerous hospitals and departments have had their patient profiles for COVID-19 patients revised as a result of the increased demand brought on by the rising incidence of COVID-19 hospitalizations. As a result, a large number of elective procedures were postponed or canceled globally in order to reserve or refocus the limited capacities and resources toward COVID-19 patient care. Additionally, there are reports of several other kinds of skin injuries among healthcare workers doing COVID-19 service tasks while wearing PPE kits. Doctors and nurses employ bioactive wound care solutions to treat such wounds while wearing grade 2 and 3 PPE kits. The market for bioactive wound care products is anticipated to develop during the COVID-19 outbreak during the forecast period as a result of such instances occurring all over the world.

Bioactive Wound Management Market: Growth Drivers

Growing demand for antimicrobial dressings to foster the market growth

Antimicrobial dressings are those used to treat wounds that contain an antiseptic substance to help kill any bacteria that may be present. These dressings are mostly used on wounds that are at a greater chance of infection as well as wounds that are failing to heal as a result of an increase in bacterial load. The increased desire to decrease hospital-acquired infections and the presence of germs that are antibiotic-resistant are further factors contributing to the increase in demand for these dressings which in turn is driving the growth of the global bioactive wound management market. Further, the market is driven by the rise in the frequency of chronic injuries and the number of surgical operations. Additionally, a spike in the size of tissue replacement surgeries and a rise in healthcare professionals' knowledge of efficient wound treatment are driving the market's expansion.

Bioactive Wound Management Market: Restraints

High costs related to bioactive wound care products to hinder the market growth

The price of receiving medical or healthcare treatment has greatly increased. Costlier chronic wound treatment and wound care management products have had a detrimental impact on their uptake, particularly in developing nations like Asia and RoW. Less pricey items are used in these regions.

Bioactive Wound Management Market: Opportunities

Advancements in the technologies in medical treatment to boost the market growth

The introduction of cutting-edge technologies and solutions for treating superficial wounds, such as biomaterials, nanotechnology, and combination dressings, is increasing the total utilization of wound care supplies. These developments provide patients with improved alleviation, acting as high-impact revenue drivers for the sector. In addition to this, small businesses have excellent R&D resources, but often lack the resources to get approvals and introduce items to the market. Large companies with sound financial standing frequently purchase these tiny companies and employ their advanced technologies to create cutting-edge products. All such factors are likely to have numerous opportunities for the growth of the global bioactive wound management market during the forecast period.

Bioactive Wound Management Market: Challenges.

Lack of studies on development of bioactive wound care products to pose challenge to the market growth.

Since wound evaluation and care is a complicated procedure including many elements that play a significant influence in the healing process, wound healing is an unmet medical concern in the health sector. Acute wounds, infected wounds, and diabetic wounds are the only uses for conductive biomaterials at this time, which are still in the experimental stage. Next, it is necessary to investigate the specific processes and if conductive biomaterials can aid in the healing of other types of wounds. The manufacturing process is an additional problem. Conducive substance production and incorporation are frequently challenging processes that can call for extreme conditions, which would limit their scope of use and cause environmental problems. Thus, more study is required for the development of bioactive wound products for wound management.

Bioactive Wound Management Market: Segmentation

The global bioactive wound management market is divided into product, end-user, and region. Based on the product, the global market is categorized into hydrocolloids dressing, antimicrobial dressing, and alginate dressing. The end-user segment comprises home care settings, long-term patient care, clinics, hospitals, and others.

Recent Developments

  • In October 2021, Hartmann USA along with Carolina Caring started a wound care program. The program's goal is to assist patients and their families in managing chronic wounds to lessen discomfort and improve recovery. The program makes use of Hartmann's specific absorbent materials to lessen the possibility of wound leakage, which can aid in lowering the possibility of infection.
  • In April 2021, in order to improve clinical understanding of chronic wounds, Medline introduced a new series of courses on chronic wound management.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Bioactive Wound Management Market: Regional Landscape

North America to dominate the global market during the forecast period

Regionally, North America is estimated to dominate the global bioactive wound management market during the forecast period. Wound care products witnessed widespread use in North America, particularly in the United States. This market is well-positioned for growth in this region because of an advanced healthcare system, a good reimbursement system, and higher patient awareness levels. Additionally, the region's high healthcare spending has aided in the continued growth of the healthcare industry. Additionally, the rising usability of injury-related items in the home healthcare market is fostering this sector's expansion. On the other hand, over the projection period, Asia Pacific is predicted to have expansion at a profitable pace. In these developing countries, the target demographic is increasingly made up of people who have diabetic foot, pressure ulcers, and infections.

Bioactive Wound Management Market: Competitive Landscape

Major players operating in the global bioactive wound management market include Systagenix Wound Management Ltd., Paul Hartmann AG, Mlnlycke Health Care AB, Smith & Nephew plc., ConvaTec Inc., Derma Sciences, Covalon Technologies Ltd., 3M Healthcare, Covidien plc, and Organogenesis Inc., among others.

Global bioactive wound management market is segmented as follows:

By Product

  • Alginate Dressing
  • Antimicrobial Dressing
  • Hydrocolloids Dressing

By End User

  • Hospitals and Clinics
  • Long-term patient care
  • Home care settings
  • Other

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Bioactive Wound Management Market, (2022 - 2028) (USD Billion)
    • 2.2 Global Bioactive Wound Management Market : snapshot
  • Chapter 3. Global Bioactive Wound Management Market - Industry Analysis
    • 3.1 Bioactive Wound Management Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Growing demand for antimicrobial dressings to foster the market growth
    • 3.3 Market Restraints
      • 3.3.1. High costs related to bioactive wound care products to hinder the market growth
    • 3.4 Market Opportunities
      • 3.4.1. Advancements in the technologies in medical treatment to boost the market growth
    • 3.5 Market Challenges
      • 3.5.1. Lack of studies on development of bioactive wound care products to pose challenge to the market growth.
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Product
      • 3.7.2 Market attractiveness analysis By End User
  • Chapter 4. Global Bioactive Wound Management Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Bioactive Wound Management Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Bioactive Wound Management Market - Product Analysis
    • 5.1 Global Bioactive Wound Management Market overview: By Product
      • 5.1.1 Global Bioactive Wound Management Market share, By Product, 2021 and 2028
    • 5.2 Alginate Dressing
      • 5.2.1 Global Bioactive Wound Management Market by Alginate Dressing, 2022 - 2028 (USD Billion)
    • 5.3 Antimicrobial Dressing
      • 5.3.1 Global Bioactive Wound Management Market by Antimicrobial Dressing, 2022 - 2028 (USD Billion)
    • 5.4 Hydrocolloids Dressing
      • 5.4.1 Global Bioactive Wound Management Market by Hydrocolloids Dressing, 2022 - 2028 (USD Billion)
  • Chapter 6. Global Bioactive Wound Management Market - End User Analysis
    • 6.1 Global Bioactive Wound Management Market overview: By End User
      • 6.1.1 Global Bioactive Wound Management Market share, By End User, 2021 and 2028
    • 6.2 Hospitals and Clinics
      • 6.2.1 Global Bioactive Wound Management Market by Hospitals and Clinics, 2022 - 2028 (USD Billion)
    • 6.3 Long-term patient care
      • 6.3.1 Global Bioactive Wound Management Market by Long-term patient care, 2022 - 2028 (USD Billion)
    • 6.4 Home care settings
      • 6.4.1 Global Bioactive Wound Management Market by Home care settings, 2022 - 2028 (USD Billion)
    • 6.5 Other
      • 6.5.1 Global Bioactive Wound Management Market by Other, 2022 - 2028 (USD Billion)
  • Chapter 7. Bioactive Wound Management Market - Regional Analysis
    • 7.1 Global Bioactive Wound Management Market Regional Overview
    • 7.2 Global Bioactive Wound Management Market Share, by Region, 2021 & 2028 (USD Billion)
    • 7.3. North America
      • 7.3.1 North America Bioactive Wound Management Market, 2022 - 2028 (USD Billion)
        • 7.3.1.1 North America Bioactive Wound Management Market, by Country, 2022 - 2028 (USD Billion)
    • 7.4 North America Bioactive Wound Management Market, by Product, 2022 - 2028
      • 7.4.1 North America Bioactive Wound Management Market, by Product, 2022 - 2028 (USD Billion)
    • 7.5 North America Bioactive Wound Management Market, by End User, 2022 - 2028
      • 7.5.1 North America Bioactive Wound Management Market, by End User, 2022 - 2028 (USD Billion)
    • 7.4. Europe
      • 7.4.2 Europe Bioactive Wound Management Market, 2022 - 2028 (USD Billion)
        • 7.4.2.1 Europe Bioactive Wound Management Market, by Country, 2022 - 2028 (USD Billion)
    • 7.4 Europe Bioactive Wound Management Market, by Product, 2022 - 2028
      • 7.4.1 Europe Bioactive Wound Management Market, by Product, 2022 - 2028 (USD Billion)
    • 7.5 Europe Bioactive Wound Management Market, by End User, 2022 - 2028
      • 7.5.1 Europe Bioactive Wound Management Market, by End User, 2022 - 2028 (USD Billion)
    • 7.5. Asia Pacific
      • 7.5.3 Asia Pacific Bioactive Wound Management Market, 2022 - 2028 (USD Billion)
        • 7.5.3.1 Asia Pacific Bioactive Wound Management Market, by Country, 2022 - 2028 (USD Billion)
    • 7.4 Asia Pacific Bioactive Wound Management Market, by Product, 2022 - 2028
      • 7.4.1 Asia Pacific Bioactive Wound Management Market, by Product, 2022 - 2028 (USD Billion)
    • 7.5 Asia Pacific Bioactive Wound Management Market, by End User, 2022 - 2028
      • 7.5.1 Asia Pacific Bioactive Wound Management Market, by End User, 2022 - 2028 (USD Billion)
    • 7.6. Latin America
      • 7.6.4 Latin America Bioactive Wound Management Market, 2022 - 2028 (USD Billion)
        • 7.6.4.1 Latin America Bioactive Wound Management Market, by Country, 2022 - 2028 (USD Billion)
    • 7.4 Latin America Bioactive Wound Management Market, by Product, 2022 - 2028
      • 7.4.1 Latin America Bioactive Wound Management Market, by Product, 2022 - 2028 (USD Billion)
    • 7.5 Latin America Bioactive Wound Management Market, by End User, 2022 - 2028
      • 7.5.1 Latin America Bioactive Wound Management Market, by End User, 2022 - 2028 (USD Billion)
    • 7.7. The Middle-East and Africa
      • 7.7.5 The Middle-East and Africa Bioactive Wound Management Market, 2022 - 2028 (USD Billion)
        • 7.7.5.1 The Middle-East and Africa Bioactive Wound Management Market, by Country, 2022 - 2028 (USD Billion)
    • 7.4 The Middle-East and Africa Bioactive Wound Management Market, by Product, 2022 - 2028
      • 7.4.1 The Middle-East and Africa Bioactive Wound Management Market, by Product, 2022 - 2028 (USD Billion)
    • 7.5 The Middle-East and Africa Bioactive Wound Management Market, by End User, 2022 - 2028
      • 7.5.1 The Middle-East and Africa Bioactive Wound Management Market, by End User, 2022 - 2028 (USD Billion)
  • Chapter 8. Company Profiles
    • 8.1 Systagenix Wound Management Ltd.
      • 8.1.1 Overview
      • 8.1.2 Financials
      • 8.1.3 Product Portfolio
      • 8.1.4 Business Strategy
      • 8.1.5 Recent Developments
    • 8.2 Paul Hartmann AG
      • 8.2.1 Overview
      • 8.2.2 Financials
      • 8.2.3 Product Portfolio
      • 8.2.4 Business Strategy
      • 8.2.5 Recent Developments
    • 8.3 Mlnlycke Health Care AB
      • 8.3.1 Overview
      • 8.3.2 Financials
      • 8.3.3 Product Portfolio
      • 8.3.4 Business Strategy
      • 8.3.5 Recent Developments
    • 8.4 Smith & Nephew plc.
      • 8.4.1 Overview
      • 8.4.2 Financials
      • 8.4.3 Product Portfolio
      • 8.4.4 Business Strategy
      • 8.4.5 Recent Developments
    • 8.5 ConvaTec Inc.
      • 8.5.1 Overview
      • 8.5.2 Financials
      • 8.5.3 Product Portfolio
      • 8.5.4 Business Strategy
      • 8.5.5 Recent Developments
    • 8.6 Derma Sciences
      • 8.6.1 Overview
      • 8.6.2 Financials
      • 8.6.3 Product Portfolio
      • 8.6.4 Business Strategy
      • 8.6.5 Recent Developments
    • 8.7 Covalon Technologies Ltd.
      • 8.7.1 Overview
      • 8.7.2 Financials
      • 8.7.3 Product Portfolio
      • 8.7.4 Business Strategy
      • 8.7.5 Recent Developments
    • 8.8 3M Healthcare
      • 8.8.1 Overview
      • 8.8.2 Financials
      • 8.8.3 Product Portfolio
      • 8.8.4 Business Strategy
      • 8.8.5 Recent Developments
    • 8.9 Covidien plc
      • 8.9.1 Overview
      • 8.9.2 Financials
      • 8.9.3 Product Portfolio
      • 8.9.4 Business Strategy
      • 8.9.5 Recent Developments
    • 8.10 Organogenesis Inc.
      • 8.10.1 Overview
      • 8.10.2 Financials
      • 8.10.3 Product Portfolio
      • 8.10.4 Business Strategy
      • 8.10.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Bioactive Wound Management Market, 2022 - 2028 (USD Billion)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Bioactive Wound Management Market attractiveness, By Product
  • 6. Global Bioactive Wound Management Market attractiveness, By End User
  • 7. Global Bioactive Wound Management Market share by Product, 2022 and 2028 (USD Billion)
  • 8. Global Bioactive Wound Management Market by Alginate Dressing, 2022 - 2028 (USD Billion)
  • 9. Global Bioactive Wound Management Market by Antimicrobial Dressing, 2022 - 2028 (USD Billion)
  • 10. Global Bioactive Wound Management Market by Hydrocolloids Dressing, 2022 - 2028 (USD Billion)
  • 11. Global Bioactive Wound Management Market share by End User, 2022 and 2028 (USD Billion)
  • 12. Global Bioactive Wound Management Market by Hospitals and Clinics, 2022 - 2028 (USD Billion)
  • 13. Global Bioactive Wound Management Market by Long-term patient care, 2022 - 2028 (USD Billion)
  • 14. Global Bioactive Wound Management Market by Home care settings, 2022 - 2028 (USD Billion)
  • 15. Global Bioactive Wound Management Market by Other, 2022 - 2028 (USD Billion)
  • 16. Global Bioactive Wound Management Market share, by Region, 2022 and 2028
  • 17. North America Bioactive Wound Management Market, 2022 - 2028 (USD Billion)
  • 18. Europe Bioactive Wound Management Market, 2022 - 2028 (USD Billion)
  • 19. Asia Pacific Bioactive Wound Management Market, 2022 - 2028 (USD Billion)
  • 20. Latin America Bioactive Wound Management Market, 2022 - 2028 (USD Billion)
  • 21. The Middle-East and Africa Bioactive Wound Management Market, 2022 - 2028 (USD Billion)

Table Of Tables

  • 1. Global Bioactive Wound Management Market: Snapshot
  • 2. Drivers of the Bioactive Wound Management Market: impact analysis
  • 3. North America Bioactive Wound Management Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 4. North America Bioactive Wound Management Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 5. U.S. Bioactive Wound Management Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 6. U.S. Bioactive Wound Management Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 7. Canada Bioactive Wound Management Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 8. Canada Bioactive Wound Management Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 9. Europe Bioactive Wound Management Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 10. Europe Bioactive Wound Management Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 11. Germany Bioactive Wound Management Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 12. Germany Bioactive Wound Management Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 13. France Bioactive Wound Management Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 14. France Bioactive Wound Management Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 15. U.K. Bioactive Wound Management Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 16. U.K. Bioactive Wound Management Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 17. Italy Bioactive Wound Management Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 18. Italy Bioactive Wound Management Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 19. Spain Bioactive Wound Management Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 20. Spain Bioactive Wound Management Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 21. Rest of Europe Bioactive Wound Management Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 22. Rest of Europe Bioactive Wound Management Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 23. Asia Pacific Bioactive Wound Management Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 24. Asia Pacific Bioactive Wound Management Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 25. China Bioactive Wound Management Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 26. China Bioactive Wound Management Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 27. Japan Bioactive Wound Management Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 28. Japan Bioactive Wound Management Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 29. India Bioactive Wound Management Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 30. India Bioactive Wound Management Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 31. South Korea Bioactive Wound Management Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 32. South Korea Bioactive Wound Management Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 33. South-East Asia Bioactive Wound Management Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 34. South-East Asia Bioactive Wound Management Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 35. Rest of Asia Pacific Bioactive Wound Management Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 36. Rest of Asia Pacific Bioactive Wound Management Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 37. Latin America Bioactive Wound Management Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 38. Latin America Bioactive Wound Management Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 39. Brazil Bioactive Wound Management Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 40. Brazil Bioactive Wound Management Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 41. Mexico Bioactive Wound Management Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 42. Mexico Bioactive Wound Management Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 43. Rest of Latin America Bioactive Wound Management Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 44. Rest of Latin America Bioactive Wound Management Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 45. The Middle-East and Africa Bioactive Wound Management Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 46. The Middle-East and Africa Bioactive Wound Management Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 47. GCC Countries Bioactive Wound Management Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 48. GCC Countries Bioactive Wound Management Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 49. South Africa Bioactive Wound Management Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 50. South Africa Bioactive Wound Management Market revenue, By End User, 2022 - 2028 (USD Billion)
  • 51. Rest of Middle-East Africa Bioactive Wound Management Market revenue, By Product, 2022 - 2028 (USD Billion)
  • 52. Rest of Middle-East Africa Bioactive Wound Management Market revenue, By End User, 2022 - 2028 (USD Billion)

Methodology

Choose License Type

FrequentlyAsked Questions

Growing demand for antimicrobial dressings to foster market growth. Further, the market is driven by the rise in the frequency of chronic injuries and the number of surgical operations. Additionally, a spike in the size of tissue replacement surgeries and a rise in healthcare professionals' knowledge of efficient wound treatment are driving the market's expansion.

According to the Zion Market Research report, the global bioactive wound management market was worth about 1.8 (USD billion) in 2021 and is predicted to grow to around 2.9 (USD billion) by 2028, with a compound annual growth rate (CAGR) of around 7.9 percent.

Regionally, North America is estimated to dominate the global bioactive wound management market during the forecast period. Wound care products witnessed widespread use in North America, particularly in the United States. This market is well-positioned for growth in this region because of an advanced healthcare system, a good reimbursement system, and higher patient awareness levels. Additionally, the region's high healthcare spending has aided in the continued growth of the healthcare industry.

Major players operating in the global bioactive wound management market include Systagenix Wound Management Ltd., Paul Hartmann AG, Mlnlycke Health Care AB, Smith & Nephew plc., ConvaTec Inc., Derma Sciences, Covalon Technologies Ltd., 3M Healthcare, Covidien plc, and Organogenesis Inc., among others.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed